US Stock MarketDetailed Quotes

Aligos Therapeutics (ALGS)

Watchlist
  • 10.330
  • +0.680+7.05%
Close Jan 8 16:00 ET
  • 10.130
  • -0.200-1.94%
Post 18:10 ET
63.57MMarket Cap-0.76P/E (TTM)

Aligos Therapeutics (ALGS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.11%-24.35M
20.46%-15.5M
8.08%-20.91M
-2.21%-80.74M
18.78%-18.4M
1.16%-20.1M
-43.16%-19.49M
-1.60%-22.75M
0.49%-79M
-35.01%-22.66M
Net income from continuing operations
-63.75%-31.54M
-413.44%-15.86M
223.59%43.09M
-49.65%-131.21M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
Operating gains losses
3,904.76%4.21M
94.48%-1.68M
-527.84%-61.49M
2,010.34%46.13M
2,764.59%62.13M
--105K
---30.48M
--14.37M
--2.19M
--2.17M
Depreciation and amortization
4.65%698K
39.02%848K
-24.33%510K
-14.57%2.62M
-13.42%671K
-2.06%667K
-20.68%610K
-20.14%674K
-16.49%3.07M
-13.60%775K
Change In working capital
148.15%1.53M
-77.38%930K
30.20%-3.84M
47.98%-4.96M
-33.11%-390K
48.69%-3.18M
539.35%4.11M
-49.58%-5.49M
-513.72%-9.53M
-133.87%-293K
-Change in payables and accrued expense
208.58%2.15M
-74.72%1.01M
32.18%-3.04M
-2.54%-1.33M
-72.93%1.12M
-12.93%-1.98M
572.70%4M
-56.91%-4.48M
82.46%-1.3M
-1.00%4.15M
-Change in other current assets
245.29%587K
144.20%337K
-172.06%-147K
-90.60%216K
74.81%-296K
121.82%170K
-93.63%138K
-90.22%204K
-56.79%2.3M
-105.06%-1.18M
-Change in other current liabilities
-13.88%-796K
-58.00%-997K
21.07%-502K
-12.32%-2.68M
-13.88%-714K
-21.57%-699K
-5.17%-631K
-8.90%-636K
-22.23%-2.39M
-1.46%-627K
-Change in other working capital
38.75%-411K
-4.30%579K
74.28%-151K
85.78%-1.16M
80.93%-504K
78.31%-671K
896.05%605K
74.73%-587K
-425.14%-8.14M
-23.62%-2.64M
Cash from discontinued investing activities
Operating cash flow
-21.11%-24.35M
20.46%-15.5M
8.08%-20.91M
-2.21%-80.74M
18.78%-18.4M
1.16%-20.1M
-43.16%-19.49M
-1.60%-22.75M
0.49%-79M
-35.01%-22.66M
Investing cash flow
Cash flow from continuing investing activities
358.58%47.68M
-198.57%-39.42M
50.29%-44.07M
-140.64%-18.28M
285,414.29%19.97M
115,633.33%10.4M
59.95%39.99M
-543.37%-88.64M
271.08%44.98M
-100.06%-7K
Net PPE purchase and sale
-642.31%-193K
-1,457.14%-109K
37.68%-43K
-584.21%-130K
-300.00%-28K
-36.84%-26K
-150.00%-7K
-885.71%-69K
97.99%-19K
92.31%-7K
Net investment purchase and sale
359.29%47.88M
-198.28%-39.31M
50.30%-44.02M
-140.33%-18.15M
--20M
104,140.00%10.42M
60.06%40M
-542.87%-88.57M
277.51%45M
--0
Cash from discontinued investing activities
Investing cash flow
358.58%47.68M
-198.57%-39.42M
50.29%-44.07M
-140.64%-18.28M
285,414.29%19.97M
115,633.33%10.4M
59.95%39.99M
-543.37%-88.64M
271.08%44.98M
-100.06%-7K
Financing cash flow
Cash flow from continuing financing activities
-1,225.00%-53K
-162.99%-177K
535,584.21%101.74M
-99.60%355K
-99.89%97K
80.95%-4K
-32.13%281K
-1,800.00%-19K
53,758.54%88.33M
72,574.38%87.94M
Net issuance payments of debt
-100.00%-10K
93.75%-1K
--0
13.54%-83K
-975.00%-43K
76.19%-5K
65.96%-16K
20.83%-19K
-57.38%-96K
-114.81%-4K
Net common stock issuance
----
---356K
--101.74M
--0
----
----
--0
--0
--17.44M
----
Proceeds from stock option exercised by employees
10,134,200.00%101.34M
----
----
-99.38%438K
-99.80%140K
--1K
-35.57%297K
--0
31,447.11%70.98M
74,896.81%70.5M
Cash from discontinued financing activities
Financing cash flow
-1,225.00%-53K
-162.99%-177K
535,584.21%101.74M
-99.60%355K
-99.89%97K
80.95%-4K
-32.13%281K
-1,800.00%-19K
53,758.54%88.33M
72,574.38%87.94M
Net cash flow
Beginning cash position
-58.42%18.77M
203.17%73.87M
-72.67%37.11M
66.67%135.77M
-49.73%35.44M
-50.32%45.15M
-69.18%24.37M
66.67%135.77M
-56.43%81.46M
-18.51%70.5M
Current changes in cash
339.88%23.29M
-365.16%-55.1M
133.00%36.77M
-281.67%-98.67M
-97.45%1.67M
52.34%-9.71M
76.08%20.78M
-4,551.65%-111.41M
151.47%54.31M
1,390.45%65.27M
End cash Position
18.66%42.06M
-58.42%18.77M
203.17%73.87M
-72.67%37.11M
-72.67%37.11M
-49.73%35.44M
-50.32%45.15M
-69.18%24.37M
66.67%135.77M
66.67%135.77M
Free cash flow
-21.92%-24.54M
19.93%-15.61M
8.17%-20.95M
-2.35%-80.87M
18.68%-18.43M
1.09%-20.13M
-43.29%-19.5M
-1.88%-22.82M
1.64%-79.02M
-34.32%-22.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.11%-24.35M20.46%-15.5M8.08%-20.91M-2.21%-80.74M18.78%-18.4M1.16%-20.1M-43.16%-19.49M-1.60%-22.75M0.49%-79M-35.01%-22.66M
Net income from continuing operations -63.75%-31.54M-413.44%-15.86M223.59%43.09M-49.65%-131.21M-194.53%-82.15M-6.75%-19.26M126.93%5.06M-51.88%-34.86M8.71%-87.68M-27.44%-27.89M
Operating gains losses 3,904.76%4.21M94.48%-1.68M-527.84%-61.49M2,010.34%46.13M2,764.59%62.13M--105K---30.48M--14.37M--2.19M--2.17M
Depreciation and amortization 4.65%698K39.02%848K-24.33%510K-14.57%2.62M-13.42%671K-2.06%667K-20.68%610K-20.14%674K-16.49%3.07M-13.60%775K
Change In working capital 148.15%1.53M-77.38%930K30.20%-3.84M47.98%-4.96M-33.11%-390K48.69%-3.18M539.35%4.11M-49.58%-5.49M-513.72%-9.53M-133.87%-293K
-Change in payables and accrued expense 208.58%2.15M-74.72%1.01M32.18%-3.04M-2.54%-1.33M-72.93%1.12M-12.93%-1.98M572.70%4M-56.91%-4.48M82.46%-1.3M-1.00%4.15M
-Change in other current assets 245.29%587K144.20%337K-172.06%-147K-90.60%216K74.81%-296K121.82%170K-93.63%138K-90.22%204K-56.79%2.3M-105.06%-1.18M
-Change in other current liabilities -13.88%-796K-58.00%-997K21.07%-502K-12.32%-2.68M-13.88%-714K-21.57%-699K-5.17%-631K-8.90%-636K-22.23%-2.39M-1.46%-627K
-Change in other working capital 38.75%-411K-4.30%579K74.28%-151K85.78%-1.16M80.93%-504K78.31%-671K896.05%605K74.73%-587K-425.14%-8.14M-23.62%-2.64M
Cash from discontinued investing activities
Operating cash flow -21.11%-24.35M20.46%-15.5M8.08%-20.91M-2.21%-80.74M18.78%-18.4M1.16%-20.1M-43.16%-19.49M-1.60%-22.75M0.49%-79M-35.01%-22.66M
Investing cash flow
Cash flow from continuing investing activities 358.58%47.68M-198.57%-39.42M50.29%-44.07M-140.64%-18.28M285,414.29%19.97M115,633.33%10.4M59.95%39.99M-543.37%-88.64M271.08%44.98M-100.06%-7K
Net PPE purchase and sale -642.31%-193K-1,457.14%-109K37.68%-43K-584.21%-130K-300.00%-28K-36.84%-26K-150.00%-7K-885.71%-69K97.99%-19K92.31%-7K
Net investment purchase and sale 359.29%47.88M-198.28%-39.31M50.30%-44.02M-140.33%-18.15M--20M104,140.00%10.42M60.06%40M-542.87%-88.57M277.51%45M--0
Cash from discontinued investing activities
Investing cash flow 358.58%47.68M-198.57%-39.42M50.29%-44.07M-140.64%-18.28M285,414.29%19.97M115,633.33%10.4M59.95%39.99M-543.37%-88.64M271.08%44.98M-100.06%-7K
Financing cash flow
Cash flow from continuing financing activities -1,225.00%-53K-162.99%-177K535,584.21%101.74M-99.60%355K-99.89%97K80.95%-4K-32.13%281K-1,800.00%-19K53,758.54%88.33M72,574.38%87.94M
Net issuance payments of debt -100.00%-10K93.75%-1K--013.54%-83K-975.00%-43K76.19%-5K65.96%-16K20.83%-19K-57.38%-96K-114.81%-4K
Net common stock issuance -------356K--101.74M--0----------0--0--17.44M----
Proceeds from stock option exercised by employees 10,134,200.00%101.34M---------99.38%438K-99.80%140K--1K-35.57%297K--031,447.11%70.98M74,896.81%70.5M
Cash from discontinued financing activities
Financing cash flow -1,225.00%-53K-162.99%-177K535,584.21%101.74M-99.60%355K-99.89%97K80.95%-4K-32.13%281K-1,800.00%-19K53,758.54%88.33M72,574.38%87.94M
Net cash flow
Beginning cash position -58.42%18.77M203.17%73.87M-72.67%37.11M66.67%135.77M-49.73%35.44M-50.32%45.15M-69.18%24.37M66.67%135.77M-56.43%81.46M-18.51%70.5M
Current changes in cash 339.88%23.29M-365.16%-55.1M133.00%36.77M-281.67%-98.67M-97.45%1.67M52.34%-9.71M76.08%20.78M-4,551.65%-111.41M151.47%54.31M1,390.45%65.27M
End cash Position 18.66%42.06M-58.42%18.77M203.17%73.87M-72.67%37.11M-72.67%37.11M-49.73%35.44M-50.32%45.15M-69.18%24.37M66.67%135.77M66.67%135.77M
Free cash flow -21.92%-24.54M19.93%-15.61M8.17%-20.95M-2.35%-80.87M18.68%-18.43M1.09%-20.13M-43.29%-19.5M-1.88%-22.82M1.64%-79.02M-34.32%-22.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More